Cristina Fillat

Dr. Cristina Fillat


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2003 in Current Gene Therapy
Verified
Journal Article
Closed access
PDF file
CFCristina Fillat
Cristina Fillat
MCM. Carrio
M. Carrio
ACA. Cascante
A. Cascante
BSBruno Sangro
Bruno Sangro
Gene-directed enzyme prodrug therapy (GDEPT) is a two step therapeutic approach for cancer gene therapy. In the first step, the transgene is delivered into the tumor and expressed. In the second step a prodrug is administered and is selectively activated by the expressed enzyme. The first GDEPT system described was the thymidine kinase gene of the Herpes Simplex virus (HSVtk) in combination with the prodrug Ganciclovir (GCV). A large number of experiments have been performed with this system, in different types of tumors and initial studies in animal models were very promising. This encouraged investigators to move into clinical trials although poor results have been obtained so far. A large effort has been made with numerous different strategies to enhance HSVtk / GCV efficacy in cellular and in vivo models and very strong cytotoxic effects have been obtained. The present review describes the current state of preclinical research and summarizes the results of the clinical trials undertaken.

1 October 2008 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
JOJon Ortiz-Abalia
Jon Ortiz-Abalia
ISIgnasi Sahún
Ignasi Sahún
XAXavier Altafaj
Xavier Altafaj
NANúria Andreu
Núria Andreu
XEXavier Estivill
Xavier Estivill
CFCristina Fillat
Cristina Fillat

1 October 2003 in The Journal of Gene Medicine
Verified
Journal Article
Closed access
PDF file
MRMarta Riera
Marta Riera
MCMiguel Chillon
Miguel Chillon
JAJosep M. Aran
Josep M. Aran
JCJosep M. Cruzado
Josep M. Cruzado
JTJoan Torras
Joan Torras
CFCristina Fillat
Cristina Fillat

18 October 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DADaniel Abate-Daga
Daniel Abate-Daga
NANuria Andreu
Nuria Andreu
JCJuan Camacho-Sánchez
Juan Camacho-Sánchez
RARamon Alemany
Ramon Alemany
JHJosé Raúl Herance
José Raúl Herance
CFCristina Fillat
Cristina Fillat
Replication-competent adenoviruses armed with thymidine kinase (TK) combine the concepts of virotherapy and suicide gene therapy. Moreover TK-activity can be detected by noninvasive positron emission-computed tomography (PET) imaging, what could potentially facilitate virus monitoring in vivo. Here, we report the generation of a novel oncolytic adenovirus that incorporates the Tat8-TK gene under the control of the Major Late Promoter in a highly selective backbone thus providing selectivity by targeting the retinoblastoma pathway. The selective oncolytic TK virus, termed ICOVIR5-TK-L, showed reduced potency compared to a non-selective counterpart. However the combination of ICOVIR5-TK-L with ganciclovir (GCV) induced a potent antitumoural effect similar to that of wild type adenovirus in a preclinical model of pancreatic cancer. Although the treatment with GCV provoked a reduction in the viral yield, both in vitro and in vivo, a two-cycle treatment of virus and GCV resulted in an enhanced antitumoral response that correlated with high TK-activity, based on microPET measurements. Thus, TK-expressing oncolytic adenoviruses can be traced by PET imaging providing real time information on the activity of the virus and its antitumoral potency can be optimized by GCV dosing.

23 August 2007 in Gene Therapy
Verified
Journal Article
Open access
ACA Cascante
A Cascante
DAD Abate-Daga
D Abate-Daga
LGL Garcia-Rodríguez
L Garcia-Rodríguez
JGJ R González
J R González
RAR Alemany
R Alemany
CFCristina Fillat
Cristina Fillat
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.

22 December 2005 in Journal of Human Genetics
Verified
Journal Article
Closed access
NANuria Andreu
Nuria Andreu
MGMaricruz García-Rodríguez
Maricruz García-Rodríguez
VVVictor Volpini
Victor Volpini
CFCecilia Frecha
Cecilia Frecha
IMIgnacio J. Molina
Ignacio J. Molina
CFCristina Fillat
Cristina Fillat